Major
Single Sales/Supply Contract
Curiox Biosystems terminated an equipment sales contract worth KRW 2.72 billion with its Chinese subsidiary on October 29, 2026.
Curiox Biosystems Co., Ltd. Disclosures
445680 · KOSDAQ · Based on DART filings
Disclosures
2 major
Major
20261027900676
Curiox Biosystems' Q3 2026 consolidated revenue was KRW 1,492 million, up 7.73% year over year and 26.87% quarter over quarter, with an operating loss of KRW 3,960 million.
Catch the next disclosure fast
Get app alerts for new disclosures from Curiox Biosystems Co., Ltd..